These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 874049)

  • 1. Increased plasma 11-deoxycorticosterone during spironolactone medication.
    Abshagen U; Spörl S; Schöneshöfer M; Oelkers W
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1190-3. PubMed ID: 874049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of spironolactone in 11-doexycorticosterone radioassays.
    Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1975 Oct; 41(4):791-2. PubMed ID: 1176585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel effects of deoxycorticosterone on testicular 11beta-hydroxysteroid dehydrogenase activity and plasma testosterone levels in normal and adrenalectomized rats.
    Nwe KH; Morat PB; Hamid A; Fadzilah S; Khalid BA
    Exp Clin Endocrinol Diabetes; 1999; 107(5):288-94. PubMed ID: 10482040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of 11-deoxycorticosterone in women during the menstrual cycle.
    Parker CR; Winkel CA; Rush AJ; Porter JC; MacDonald PC
    Obstet Gynecol; 1981 Jul; 58(1):26-30. PubMed ID: 6454093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of serum deoxycorticosterone: normal values and changes of serum deoxycorticosterone after adrenal stimulation.
    Schöneshöfer M; Oelkers W; Harendt H
    Z Klin Chem Klin Biochem; 1975 Apr; 13(4):143-7. PubMed ID: 168695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma corticosteroid concentrations during spironolactone administration: evidence for adrenal biosynthetic blockade in man.
    Tuck ML; Sowers JR; Fittingoff DB; Fisher JS; Berg GJ; Asp ND; Mayes DM
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1057-61. PubMed ID: 6262360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and urinary 19-nor-deoxycorticosterone in 17 alpha-hydroxylase deficiency syndrome.
    Griffing GT; Wilson TE; Holbrook MM; Dale SL; Jackson TK; Ullrich I; Melby JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1011-5. PubMed ID: 6332824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of deoxycorticosterone and its relationship to progesterone in the prepartum bovine.
    Wise TH; Sorensen AM; Fleeger JL
    Steroids; 1975 Jul; 26(1):17-28. PubMed ID: 1166481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low renin essential hypertension: failure to demonstrate excess 11-deoxycorticosterone production.
    Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1979 Nov; 49(5):790-3. PubMed ID: 489719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The measurement of 18-hyroxy-11-deoxycorticosterone in human plasma by radioimmunoassay.
    Chandler DW; Tuck M; Mayes DM
    Steroids; 1976 Feb; 27(2):235-46. PubMed ID: 944958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference in the measurement of plasma 11-hydroxycorticosteroids caused by spironolactone administration.
    Wood LC; Richards R; Ingbar SH
    N Engl J Med; 1970 Mar; 282(12):650-2. PubMed ID: 5417730
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioimmunoassay for urinary free 19-nor-deoxycorticosterone: effects of adrenocorticotropin and sodium depletion.
    Gomez-Sanchez CE; Gomez-Sanchez EP; Upcavage RJ
    Endocrinology; 1983 Jun; 112(6):2046-9. PubMed ID: 6303757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional properties of deoxycorticosterone and spironolactone: molecular characterization and effects on sleep-endocrine activity.
    Steiger A; Rupprecht R; Spengler D; Guldner J; Hemmeter U; Rothe B; Damm K; Holsboer F
    J Psychiatr Res; 1993; 27(3):275-84. PubMed ID: 8295159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A radioimmunoassay of plasma 18-hydroxy-11-deoxycorticosterone.
    Den K; Honda M; Kambegawa A; Tomita M; Tochigi B; Yoshida T; Takagi S
    Endocrinol Jpn; 1978 Apr; 25(2):171-5. PubMed ID: 668629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A competitive protein binding radioassay for deoxycorticosterone in human plasma.
    Tan SY; Mulrow PJ
    Steroids; 1975 Jan; 25(1):1-12. PubMed ID: 1111169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic ethanol administration elevates deoxycorticosterone levels and chronic ethanol exposure attenuates this response.
    Khisti RT; Boyd KN; Kumar S; Morrow AL
    Brain Res; 2005 Jul; 1049(1):104-11. PubMed ID: 15936001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute anticonvulsant effects of deoxycorticosterone in developing rats: role of metabolites and mineralocorticoid-receptor responses.
    Edwards HE; Vimal S; Burnham WM
    Epilepsia; 2005 Dec; 46(12):1888-97. PubMed ID: 16393154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man.
    Williams GH; Braley LM; Underwood RH
    J Clin Invest; 1976 Jul; 58(1):221-9. PubMed ID: 180059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassays for aldosterone and deoxycorticosterone in plasma and urine.
    Kurtz AB; Bartter FC
    Steroids; 1976 Jul; 28(1):133-42. PubMed ID: 960145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.